Also, FABP4 concentration is associated with both the development and severity of cardiovascular diseases (CVDs) including hypertension (Chen et al., 2017), coronary artery disease (Kralisch & Fasshauer, 2013), ischemic stroke (Hansen et al., 2021), and fatal arrhythmia (Wang et al., 2019). Here, FABP4 is linked to cardiovascular disorder.